Atracurium is a non-depolarizing benzylisoquinolinium neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation… Read more





























Atracurium is a non-depolarizing benzylisoquinolinium neuromuscular blocking agent used as an adjunct to general anesthesia to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. It functions by competitively inhibiting acetylcholine receptors at the neuromuscular junction, preventing nerve-to-muscle transmission. The range of associated products includes high-quality reference standards essential for pharmaceutical laboratories performing rigorous impurity profiling and method validation. These collections feature a comprehensive array of pharmacopeial and non-pharmacopeial impurities, common metabolites such as laudanosine, and stable isotope labelled compounds. These materials play a critical role in quality control, allowing scientists to accurately identify degradation products, ensure process consistency, and maintain compliance with stringent regulatory standards during the development and analytical testing of neuromuscular-blocking drug formulations.